Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Code:
NCT06295159
Conditions
Melanoma Stage III
Melanoma Stage IV
Advanced Melanoma
Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nivolumab
Nivolumab + Relatlimab
Ipilimumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-27. This information was provided to ClinicalTrials.gov by H. Lee Moffitt Cancer Center and Research Institute on 2025-06-11.